| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/21/2013 | US8445690 Aminothiazolones as estrogen related receptor-alpha modulators |
| 05/21/2013 | US8445689 Pesticides |
| 05/21/2013 | US8445687 Process for the preparation of a RAF kinase inhibitor and intermediates for use in the process |
| 05/21/2013 | US8445686 4-(4-pyridinyl)-benzamides and their use as rock activity modulators |
| 05/21/2013 | US8445683 Porphyrin compounds comprising one or more pyridone moieties |
| 05/21/2013 | US8445681 Azaindazoles useful as inhibitors of kinases |
| 05/21/2013 | US8445680 Tetrahydrothieno pyridines |
| 05/21/2013 | US8445679 7-substituted indole MCL-1 inhibitors |
| 05/21/2013 | US8445676 Pyrrolotriazine kinase inhibitors |
| 05/21/2013 | US8445653 Freeze-dried preparation of stabilized anthracycline compound |
| 05/21/2013 | US8445644 ErbB interface peptidomimetics and methods of use thereof |
| 05/21/2013 | US8445637 SPARC binding peptides and uses thereof |
| 05/21/2013 | US8445544 Hydrolysable polymeric FMOC-linker |
| 05/21/2013 | US8445543 Combinations of adapalene and benzoyl peroxide for treating acne lesions |
| 05/21/2013 | US8445542 Methods of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals |
| 05/21/2013 | US8445541 Methods for concomitant administration of colchicine and a second active agent |
| 05/21/2013 | US8445540 Regulation of osteopontin |
| 05/21/2013 | US8445539 Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders |
| 05/21/2013 | US8445538 Glucagon receptor antagonist compounds |
| 05/21/2013 | US8445537 Compounds that inhibit human DNA ligases and methods of treating cancer |
| 05/21/2013 | US8445536 Arginine-containing compositions and methods for increasing blood flow using same |
| 05/21/2013 | US8445535 Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
| 05/21/2013 | US8445534 Treating androgen decline in aging male (ADAM)-associated conditions with SARMs |
| 05/21/2013 | US8445533 Andrographolide derivatives to treat viral infections |
| 05/21/2013 | US8445532 To enhance the sensitivity of drug-resistant tumor cells to chemotherapeutic drugs; treating P-gp or Bcl-2 over-expression, or glyoxylase I over-activity; phthalide derivatives such as dimers and spiro-ring derivatives, obtained as plant extracts from ligusticus wallichii franchet or angelica |
| 05/21/2013 | US8445530 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 05/21/2013 | US8445529 Indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 05/21/2013 | US8445528 Dendrimer conjugates |
| 05/21/2013 | US8445527 Organic compounds and their uses |
| 05/21/2013 | US8445526 Compositions and methods for treatment of glaucoma |
| 05/21/2013 | US8445525 Carboxylic acid amides, the preparation thereof and their use as medicaments |
| 05/21/2013 | US8445524 Solid forms of bendamustine hydrochloride |
| 05/21/2013 | US8445523 Dioxo-imidazolidine derivatives, which inhibit the enzyme SOAT-1, and pharmaceutical and cosmetic compositions containing them |
| 05/21/2013 | US8445522 Substituted 2-(4-pyridyl)benzoxazoles, and compositions thereof, for use in arthropod pest control |
| 05/21/2013 | US8445520 Tricyclic compounds, compositions, and methods |
| 05/21/2013 | US8445519 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof |
| 05/21/2013 | US8445518 Triazolyl pyridyl benzenesulfonamides |
| 05/21/2013 | US8445517 Stat modulators |
| 05/21/2013 | US8445516 Pharmaceutical composition for promoting angiogenesis |
| 05/21/2013 | US8445515 C5aR antagonists |
| 05/21/2013 | US8445514 Urotensin II receptor antagonists |
| 05/21/2013 | US8445513 α-Aminoamide derivatives useful in the treatment of restless legs syndrome |
| 05/21/2013 | US8445512 Substituted quinoline-3-carboxamides as KCNQ2/3 modulators |
| 05/21/2013 | US8445511 Quinoline or quinoxaline derivatives for treating neurodegenerative diseases |
| 05/21/2013 | US8445510 Fused bicyclic kinase inhibitors |
| 05/21/2013 | US8445509 Fused heterocyclic derivatives and use thereof |
| 05/21/2013 | US8445508 Method of restoring the incretin effect |
| 05/21/2013 | US8445507 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
| 05/21/2013 | US8445506 Polymorphs of lopinavir |
| 05/21/2013 | US8445505 Pyrimidine derivatives as kinase inhibitors |
| 05/21/2013 | US8445504 Tricyclic pyrazolopyrimidine derivatives |
| 05/21/2013 | US8445503 Inhibitors of polo-like kinase |
| 05/21/2013 | US8445502 Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same |
| 05/21/2013 | US8445501 Substituted 7-carboxamido-pyrrolo[3,2-d]pyrimidines |
| 05/21/2013 | US8445497 Compounds for the treatment of hepatitis C |
| 05/21/2013 | US8445496 Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the same |
| 05/21/2013 | US8445495 Certain Chemical entities, compositions and methods |
| 05/21/2013 | US8445494 Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| 05/21/2013 | US8445493 Tetrasubstituted pyridazines hedgehog pathway antagonists |
| 05/21/2013 | US8445492 Method for inhibiting growth of cancer cells and cell telomere and diseases of cell proliferation by using heteroannelated anthraquinone derivative compounds |
| 05/21/2013 | US8445490 Compounds for the treatment of hepatitis C |
| 05/21/2013 | US8445489 Aryl ether pyridazinone derivatives |
| 05/21/2013 | US8445488 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors |
| 05/21/2013 | US8445487 Purine PI3K inhibitor compounds and methods of use |
| 05/21/2013 | US8445486 Triazine compounds as PI3 kinase and mTOR inhibitors |
| 05/21/2013 | US8445485 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 05/21/2013 | US8445484 Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases |
| 05/21/2013 | US8445483 Anti-infective agents against intracellular pathogens |
| 05/21/2013 | US8445482 Thieno- and furo-pyrimidine modulators of the histamine H4 receptor |
| 05/21/2013 | US8445481 Scaffold-diversified pyrrolidinone derivatives and their use |
| 05/21/2013 | US8445480 CETP inhibitors derived from benzoxazole arylamides |
| 05/21/2013 | US8445479 Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity |
| 05/21/2013 | US8445478 Azetidine derivatives, their preparation and their application in therapy |
| 05/21/2013 | US8445477 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 05/21/2013 | US8445476 Carbacephem β-lactam antibiotics |
| 05/21/2013 | US8445475 Supramolecular complexes as photoactivated DNA cleavage agents |
| 05/21/2013 | US8445474 Compositions of R(+) and S(−) pramipexole and methods of using the same |
| 05/21/2013 | US8445472 TGR5 modulators and methods of use thereof |
| 05/21/2013 | US8445471 Process for obtaining steroidal phosphate compounds |
| 05/21/2013 | US8445470 Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists |
| 05/21/2013 | US8445469 18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter |
| 05/21/2013 | US8445468 (20S,22E)-2-methylene-19-nor-22-ene-1α,25-dihydroxyvitamin D3 |
| 05/21/2013 | US8445467 Reducing risk of type 2 diabetes (T2D) |
| 05/21/2013 | US8445464 Methods of use of biomaterial and injectable implant containing biomaterial |
| 05/21/2013 | US8445463 Methods of use of biomaterial and injectable implant containing biomaterial |
| 05/21/2013 | US8445462 Composition for the treatment of osteoarthritis |
| 05/21/2013 | US8445461 Pharmaceutical composition for meniere's disease |
| 05/21/2013 | US8445460 Soluble, highly branched glucose polymers for enteral and parenteral nutrition and for peritoneal dialysis |
| 05/21/2013 | US8445458 Food composition for prodromal dementia patients |
| 05/21/2013 | US8445457 Oral pharmaceutical solutions containing telbivudine |
| 05/21/2013 | US8445456 Use of RNA interference for treating or reducing pain |
| 05/21/2013 | US8445455 Stress-responsive induction of a therapeutic agent and methods of use |
| 05/21/2013 | US8445452 Fulvic acid and antibiotic combination |
| 05/21/2013 | US8445451 Macrolides and uses of macrolides |
| 05/21/2013 | US8445450 Antithrombotic dual inhibitors comprising a biotin residue |
| 05/21/2013 | US8445444 Compositions and methods for diagnosing, treating, and preventing prostate conditions |
| 05/21/2013 | US8445437 Treatment and prevention of cardiovascular disease using mast cell stabilizers |
| 05/21/2013 | US8445436 Oxytocin and melatonin compositions and associated methods for inducing labor |
| 05/21/2013 | US8445435 Mast cell stabilizers in the treatment of obesity |
| 05/21/2013 | US8445427 Endotoxin adsorbent, and method for removing endotoxin using the same |